You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Targeting B-cell lymphoma with Leukothera-phase II
SBC: Actinobac Biomed, Inc. Topic: NCIDESCRIPTION provided by applicant B cell lymphoma is cancer of B lymphocytes and accounts for more than deaths in the U S each year While many patients respond to currently available therapy there is a high rate of cancer relapse and inability for the patients o tolerate chemotherapy Thus there is a significant need to make available to these patients newer therapies that are more e ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A Novel Approach to Assessing Cognitive State During Real-World Tasks
SBC: ADVANCED BRAIN MONITORING, INC. Topic: 105DESCRIPTION provided by applicant In Phase our team was able to enhance the ABM B Alert system for use in on the road evaluations by reducing the overall profile of the hardware system introducing real time commenting for marking events in real world activities and assessing and confirming current artifact rejection algorithms for sufficiency in real world environments In addition the ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
SBC: Apogee Biotechnology Corporation Topic: 102DESCRIPTION provided by applicant Diffuse large B cell lymphoma DLBCL represents one of the most common variants of Non Hodgkinandapos s lymphoma NHL and oncogenic herpesviruses EBV and KSHV are the etiologic agents for the majority of these tumors in patients over or those infected with the human immunodeficiency virus HIV Despite modest improvements in outcomes for patients rece ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A Short Instrumented Test of Mobility for Neurological Disorders
SBC: APDM, INC. Topic: NICHDDESCRIPTION provided by applicant APDM is a young company focused on developing and commercializing professional systems using wearable inertial sensors for monitoring of human movement and movement disorders In Phase I we developed the novel Instrumented Stand and Walk test ISAW using APDMandapos s proprietary Opal movement monitors and Mobility Lab system We validated the ISAW by demon ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Experience Success: Virtual Reality Skills Training to Enhance e-Weight Loss
SBC: VIRTUALLY BETTER INC Topic: 300DESCRIPTION provided by applicant Overweight and obesity are major health problems affecting over two thirds of US adults Commercially available Internet based weight loss programs are currently used by millions of overweight obese individuals in the U S but weight losses are often poor likely because these products on the whole do not incorporate empirically validated behavioral weight los ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety
SBC: VIRTUALLY BETTER INC Topic: NIMHDESCRIPTION provided by applicant Anxiety disorders are the most common psychiatric disorders among youth with lifetime prevalence ranging between of the general population Among anxiety disorders social anxiety disorder SAD affects of all youth resulting in significant short and long term impairment including increased likelihood of substance abuse limited academic achievemen ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Automated Image-based Biomarker Computation Tools for Diabetic Retinopathy
SBC: EYENUK, INC. Topic: NCATSDESCRIPTION provided by applicant In this STTR project we present EyeMark a set of advanced image analysis tools for automated computation of biomarkers for diabetic retinopathy DR using retinal fundus images Specifically we will develop tools for computation of microaneurysm MA appearance and disappearance rates jointly known as turnover rates for use as a biomarker in quantifying D ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Antigen Detection assay for the Diagnosis of Melioidosis
SBC: Inbios International Inc Topic: NIAIDDESCRIPTION provided by applicant Burkholderia pseudomallei is a Gram negative bacterium that is the causative agent of melioidosis The bacterium causes significant morbidity and mortality in tropical regions and endemic areas are expanding Melioidosis is difficult to trea and diagnose due to the fact that B pseudomallei is resistant to common antibiotics and symptoms are non specific Morta ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
CG-GRID: Computational Genetics Grid Resource for Interaction Discovery
SBC: PARABON COMPUTATION, INC. Topic: 400DESCRIPTION provided by applicant Advances in DNA sequencing technology have now made it practical and affordable to generate datasets containing millions of genetic attributes that can be tested for association with disease susceptibility The computational complexity of searching for genetic interactions over such high dimensional datasets imposes great challenges for genome wide associatio ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Preclinical development of novel small molecule malaria drugs that overcome drug
SBC: DESIGNMEDIX, INC. Topic: NIAIDDESCRIPTION provided by applicant The worldwide health problem created by malaria has been made more difficult by the spread of drug resistant parasites We have developed an orally available and inexpensive class of novel drugs that act against both chloroquine resistant and chloroquine sensitive malaria This project carries on preclinical development of a drug candidate that has been select ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health